ArticleLung cancer (Amsterdam, Netherlands)2015

Phase 1 study of romidepsin plus erlotinib in advanced non-small cell lung cancer.

David E Gerber et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.